13F-HR filed by Monashee Investment Management LLC
Monashee Investment Management LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 27 holding rows worth $274,728,000.
- Accession
- 0001606587-22-001754
- Filer
- CIK 1627608
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 28 entries on the cover page, a total value of $274,728,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $274,728,000 with VALUE read as thousands by filing date, 13F file number 028-16854. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 1,196,400 | $225,665,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 240,000 | $4,198,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 925,000 | $4,181,000 | thousands by filing date | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,742,490 | $3,886,000 | thousands by filing date | |
| American Tower Corporation | 03027X100 | COM | 15,000 | $3,834,000 | thousands by filing date | |
| ALBERTSONS COMPANIES INC COMMON STOCK | 013091103 | Stock | 125,000 | $3,340,000 | thousands by filing date | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,230,441 | $3,261,000 | thousands by filing date | |
| DOCGO INC | 256086109 | COM | 385,058 | $2,749,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 85,000 | $2,586,000 | thousands by filing date | |
| VIEW INC | 92671V106 | COM | 1,500,000 | $2,430,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 122,129 | $2,208,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 319,536 | $2,195,000 | thousands by filing date | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 233,330 | $1,808,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 95,000 | $1,772,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 45,000 | $1,768,000 | thousands by filing date | |
| GAMING & LEISURE P COM | 36467J108 | REIT | 33,908 | $1,555,000 | thousands by filing date | |
| EUROPEAN WAX CTR INC | 29882P106 | CLASS A COM | 67,000 | $1,181,000 | thousands by filing date | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 80,000 | $1,056,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 200,000 | $1,050,000 | thousands by filing date | |
| REVELATION BIOSCIENCES INC | 76135L101 | COM | 817,562 | $907,000 | thousands by filing date | |
| AXIA ENERGIA SA | 15234Q207 | SPONSORED ADR | 100,030 | $887,000 | thousands by filing date | |
| PROFRAC HLDG CORP | 74319N100 | CLASS A COM | 30,000 | $549,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 30,000 | $537,000 | thousands by filing date | |
| LUFAX HOLDING LTD | 54975P102 | ADS REP SHS CL A | 85,000 | $510,000 | thousands by filing date | |
| ASPEN AEROGELS INC | 04523Y105 | COMMON STOCK | 37,500 | $371,000 | thousands by filing date | |
| IVANHOE ELECTRIC INC US | 46578C108 | COMMON STOCK | 25,246 | $220,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 127,280 | $24,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001606587-22-001754 | this filing | 2022-08-12 | acceptance time not in the bulk data set |